English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12145/12927 (94%)
造访人次 : 853374      在线人数 : 861
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻
    主页 ‧ 登入 ‧ 上传 ‧ 说明 ‧ 关于NHRI ‧ 管理 到手机版

    子类别

    圖書 [5/7]
    會議論文/會議摘要 [25/32]
    期刊論文 [158/158]

    邻近社群


    MARK LAWRENCE WAHLQVIST(2008-2012) [138/140]
    吳易謙 [54/55]
    吳秀英 [10/10]
    廖本揚 [39/39]
    廖玉潔 [63/65]
    張新儀 [245/268]
    李孟智 [51/54]
    李蘭 [28/28]
    林培生 [25/25]
    林煜軒 [47/47]
    林肇堂 [35/35]
    梁賡義 [15/15]
    江博煌 [72/78]
    溫啟邦(2001-2010) [177/188]
    潘文涵 [110/115]
    熊昭 [369/379]
    莊淑鈞 [43/44]
    莊紹源 [162/168]
    蔡慧如 [162/165]
    蔡憶文(1999-2010) [34/34]
    藍祚運(2003-2011) [22/23]
    許志成 [385/393]
    邱亞文(2005-2013) [63/99]
    邱弘毅 [49/49]
    邱燕楓 [82/82]
    郭耿南(2003-2010) [89/105]
    鄒小蕙 [101/105]
    鍾仁華 [85/86]
    陳主智 [61/61]
    陳慶餘(2006-2010) [70/70]
    陳美惠 [32/32]
    陳豐奇 [53/55]
    陳麗光 [106/106]
    黃國晉 [15/15]
    丘政民(2000-2004) [8/8]
    其他 [238/244]
    劉仁沛(1998-2002) [64/65]
    姚姿君(1999-2002) [3/3]
    戴東原(2003-2005) [21/22]
    李明亮(2003-2007) [6/6]
    林仲彥(1999-2005) [31/33]
    林錦瑜(2002-2003) [5/5]
    涂醒哲(2003-2004) [4/4]
    石曜堂(1999-2006) [20/24]
    蔡碧紋(2004-2006) [3/4]
    陳淑媛(2001-2004) [3/3]

    社群统计


    近3年内发表的文件:19(9.64%)
    含全文笔数:188(95.43%)

    文件下载次数统计
    下载大于0次:188(100.00%)
    下载大于100次:177(94.15%)
    全文下载总次数:94937(1.77%)

    最后更新时间: 2024-11-28 16:03

    上传排行

    数据加载中.....

    下载排行

    数据加载中.....

    RSS Feed RSS Feed
    跳至:
    或输入年份:
    由新到旧排序 由最旧的开始

    显示项目1-25 / 197. (共8页)
    1 2 3 4 5 6 7 8 > >>
    每页显示[10|25|50]项目

    日期题名關聯
    2024-10 A phase 1 study of biweekly nab-paclitaxel/oxaliplatin/S-1/LV for advanced upper gastrointestinal cancers: TCOG T1216 study Oncologist. 2024 Oct 3;29(10):e1396-e1405.
    2024-09-30 Registry of genetic alterations of Taiwan non-small cell lung cancer by comprehensive next-generation sequencing: A real-world cohort study-Taiwan cooperative oncology group T1521 JCO Global Oncology. 2024 Sep 30;10:Article number e2400125.
    2024-08-28 A statistical method for protocol modifications with heterogeneous population variances Statistics in Biopharmaceutical Research. 2024 Aug 28;Article in Press.
    2024-08-21 Immune killer cells treatment for previously treated stage IV NSCLC patients Scientific Reports. 2024 Aug 21;14:Article number 19374.
    2024-07-11 Survival of advanced/recurrent gastrointestinal stromal tumors treated with tyrosine kinase inhibitors in Taiwan: A nationwide registry study BMC Cancer. 2024 Jul 11;24:Article number 828.
    2024-06-24 The clinical characteristics and manifestation of anxious depression among patients with major depressive disorders-results from a Taiwan multicenter study Psychiatry Investigation. 2024 Jun 24;21(6):561-572.
    2023-11-13 Polygenic risk score, environmental tobacco smoke, and risk of lung adenocarcinoma in never-smoking women in Taiwan JAMA Network Open. 2023 Nov 13;6(11):Article number e2339254.
    2023-11 Nivolumab plus ipilimumab (N plus I) for potentially resectable hepatocellular carcinoma (HCC): Efficacy and surgical outcome Annals of Oncology. 2023 Nov;34(Suppl. 3):S1390.
    2023-11 The registry of genetic alterations of Taiwan NSCLC by comprehensive next-generation sequencing: A real-world cohort study - TCOG T1521 study Journal of Thoracic Oncology. 2023 Nov;18(11, Suppl.):S52.
    2023-05-26 Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population Nature Communications. 2023 May 26;14:Article number 3043.
    2023-05 Bayesian hierarchical models for adaptive basket trial designs Pharmaceutical Statistics. 2023 May-Jun;22(3):531-546.
    2022-12 Recalibrating risk prediction models by synthesizing data sources: Adapting the lung cancer PLCO model for Taiwan Cancer Epidemiology, Biomarkers and Prevention. 2022 Dec 5;31(12):2208-2218.
    2022-11 BEAR study: A single-arm, phase II trial of BI-754091 and afatinib for refractory esophageal squamous cell carcinoma Annals of Oncology. 2022 Nov;33(Suppl. 9):S1472-S1473.
    2022-10 Impaired chromatin remodeling predicts better survival to modified gemcitabine and S-1 plus nivolumab in advanced biliary tract Cancer: A phase II T1219 study Clinical Cancer Research. 2022 Oct 3;28(19):4248-4257.
    2022-07 A phase II trial of nivolumab, gemcitabine and S-1 as the frst-line treatment in patients with biliary tract cancer Annals of Oncology. 2022 Jul;33(Suppl. 6):S478.
    2022-06-02 Trial Designs for integrating novel therapeutics into the management of intermediate-stage hepatocellular carcinoma Journal of Hepatocellular Carcinoma. 2022 Jun 2;9:517-536.
    2022-06 Three-stage pooled plasma hepatitis C virus RNA testing for the identification of acute HCV infections in at-risk populations Microbiology Spectrum. 2022 Jun 29;10(3):Article number e0243721.
    2022-01 Use of likelihood estimates for variances for the design and evaluation of multiregional clinical trials with heterogeneous variances Statistics in Medicine. 2022 Jan 15;41(1):87-107.
    2022-01 Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients Clinical and Translational Radiation Oncology. 2022 Jan;32:59-68.
    2021-11-12 The prognostic and predictive role of chromogranin a in gastroenteropancreatic neuroendocrine tumors - A single-center experience Frontiers in Oncology. 2021 Nov 12;11:Article number 741096.
    2021-09-27 Comment on"Biostatistical considerations when using RWD and RWE in clinical studies for regulatory purposes: A landscape assessment": Is real-world evidence real? Statistics in Biopharmaceutical Research. 2021 Sep 27;15(1):18-19.
    2021-09 A phase II trial of nivolumab and gemcitabine and S-1 as the first-line treatment in patients with advanced biliary tract cancer Annals of Oncology. 2021 Sep;32(Suppl. 5):S377.
    2021-05 High expression of krüppel-like factor 10 or Smad4 predicts clinical benefit of adjuvant chemoradiotherapy in curatively resected pancreatic adenocarcinoma: From a randomized phase III trial Radiotherapy and Oncology. 2021 May;158:146-154.
    2021-05 TCOG T5217 trial: A phase II randomized study of SLOG versus modified FOLFIRINOX as the first-line treatment in locally advanced or metastatic pancreatic ductal adenocarcinoma Journal of Clinical Oncology. 2021 May;39(15, Suppl.):4143.
    2021-05 A phase 2 study of liposomal irinotecan with 5-fluorouracil and leucovorin in squamous cell carcinoma of head and neck or esophagus after prior platinum-based chemotherapy or chemoradiotherapy Journal of Clinical Oncology. 2021 May;39(15, Suppl.):Abstract number 6025.

    显示项目1-25 / 197. (共8页)
    1 2 3 4 5 6 7 8 > >>
    每页显示[10|25|50]项目

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈